Scilex Holding (SCLX) EBITDA (2020 - 2026)
Scilex Holding (SCLX) posted quarterly EBITDA of -$32.2 million for Q1 2026, down 15.31% year-over-year from -$38.0 million in Q1 2025, and up 71.04% quarter-over-quarter from -$111.1 million in Q4 2025.
Scilex Holding (SCLX) EBITDA (2020 - 2026) Analysis & Trends
Scilex Holding's EBITDA history runs 7 years deep, the most recent figure standing at -$32.2 million for Q1 2026.
- In Q1 2026, EBITDA fell 15.31% year-over-year to -$32.2 million; the TTM figure through Mar 2026 stood at -$350.3 million (down 281.5% YoY), while the FY2025 annual figure was -$346.0 million, down 314.9% from the prior year.
- EBITDA for Q1 2026 stood at -$32.2 million, up from -$111.1 million in the prior quarter.
- The five-year high for EBITDA was -$8.8 million in Q1 2022, with the low at -$186.5 million in Q3 2025.
- The 5-year median for EBITDA is -$20.5 million (2025), against an average of -$36.3 million.
- The sharpest annual moves came in 2022 and 2024: EBITDA sank 6563.76% in 2022, then soared 48.67% in 2024.
- Scilex Holding's EBITDA stood at -$19.7 million in 2022, then increased by 7.1% to -$18.3 million in 2023, then plunged by 54.74% to -$28.4 million in 2024, then tumbled by 291.47% to -$111.1 million in 2025, then surged by 71.04% to -$32.2 million in 2026.
- Business Quant data shows SCLX's EBITDA at -$32.2 million in Q1 2026, -$111.1 million in Q4 2025, and -$186.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 645.35 Mn |
| 10 | Scilex Holding | 39.35 Mn | -73.44 Mn | 3.97 Mn | -29.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.17 Mn |
| Dec 31, 2025 | -111.09 Mn |
| Sep 30, 2025 | -186.51 Mn |
| Jun 30, 2025 | -20.51 Mn |
| Mar 31, 2025 | -27.90 Mn |
| Dec 31, 2024 | -28.38 Mn |
| Sep 30, 2024 | -19.92 Mn |
| Jun 30, 2024 | -15.62 Mn |
| Mar 31, 2024 | -19.48 Mn |
| Dec 31, 2023 | -18.34 Mn |
| Sep 30, 2023 | -38.81 Mn |
| Jun 30, 2023 | -22.81 Mn |
| Mar 31, 2023 | -25.47 Mn |
| Dec 31, 2022 | -19.74 Mn |
| Sep 30, 2022 | -10.62 Mn |
| Jun 30, 2022 | -11.47 Mn |
| Mar 31, 2022 | -8.81 Mn |
| Dec 31, 2021 | -35.22 Mn |
| Sep 30, 2021 | -283,346.00 |
| Jun 30, 2021 | -172,140.00 |